§ Funding Round
Series C funding round for Tessera Therapeutics raising $300M in April 2022
Series C funding round for Tessera Therapeutics raising $300M in April 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Flagship Ventures | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Hanwha Impact | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | vali barsan | |
T. Rowe Price Associates | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$530M
Top Valuation
-
Tessera raised $300M in a Series C round.
The round was announced on 04/01/22.
